Vertex Pharmaceuticals Incorporated (ETR:VX1)

Vertex Pharmaceuticals Statistics

Total Valuation

ETR:VX1 has a market cap or net worth of EUR 91.54 billion. The enterprise value is 82.72 billion.

Market Cap	91.54B
Enterprise Value	82.72B

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	253.72M
Shares Outstanding	n/a
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	0.21%
Owned by Institutions (%)	95.98%
Float	252.91M

Valuation Ratios

The trailing PE ratio is 29.23 and the forward PE ratio is 20.36.

PE Ratio	29.23
Forward PE	20.36
PS Ratio	9.16
PB Ratio	6.20
P/TBV Ratio	6.80
P/FCF Ratio	32.18
P/OCF Ratio	28.89
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.48, with an EV/FCF ratio of 29.08.

EV / Earnings	26.41
EV / Sales	8.14
EV / EBITDA	19.48
EV / EBIT	21.04
EV / FCF	29.08

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.11.

Current Ratio	2.36
Quick Ratio	1.84
Debt / Equity	0.11
Debt / EBITDA	0.37
Debt / FCF	0.55
Interest Coverage	354.41

Financial Efficiency

Return on equity (ROE) is 22.31% and return on invested capital (ROIC) is 15.51%.

Return on Equity (ROE)	22.31%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	15.51%
Return on Capital Employed (ROCE)	22.25%
Revenue Per Employee	1.64M
Profits Per Employee	513,490
Employee Count	6,100
Asset Turnover	0.50
Inventory Turnover	4.10

Taxes

In the past 12 months, ETR:VX1 has paid 659.34 million in taxes.

Income Tax	659.34M
Effective Tax Rate	17.39%

Stock Price Statistics

The stock price has decreased by -20.79% in the last 52 weeks. The beta is 0.46, so ETR:VX1's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-20.79%
50-Day Moving Average	346.71
200-Day Moving Average	394.00
Relative Strength Index (RSI)	53.72
Average Volume (20 Days)	119

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.18

Income Statement

In the last 12 months, ETR:VX1 had revenue of EUR 9.99 billion and earned 3.13 billion in profits. Earnings per share was 12.12.

Revenue	9.99B
Gross Profit	5.27B
Operating Income	3.87B
Pretax Income	3.79B
Net Income	3.13B
EBITDA	4.02B
EBIT	3.87B
Earnings Per Share (EPS)	12.12

Balance Sheet

The company has 5.36 billion in cash and 1.56 billion in debt, giving a net cash position of 8.67 billion.

Cash & Cash Equivalents	5.36B
Total Debt	1.56B
Net Cash	8.67B
Net Cash Per Share	n/a
Equity (Book Value)	14.76B
Book Value Per Share	58.12
Working Capital	5.19B

Cash Flow

In the last 12 months, operating cash flow was 3.17 billion and capital expenditures -324.56 million, giving a free cash flow of 2.84 billion.

Operating Cash Flow	3.17B
Capital Expenditures	-324.56M
Free Cash Flow	2.84B
FCF Per Share	n/a

Margins

Gross margin is 52.72%, with operating and profit margins of 38.70% and 31.35%.

Gross Margin	52.72%
Operating Margin	38.70%
Pretax Margin	37.95%
Profit Margin	31.35%
EBITDA Margin	40.19%
EBIT Margin	38.70%
FCF Margin	28.47%

Dividends & Yields

ETR:VX1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	3.42%
FCF Yield	3.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 24, 2000. It was a forward split with a ratio of 2.

Last Split Date	Aug 24, 2000
Split Type	Forward
Split Ratio	2

Scores

ETR:VX1 has an Altman Z-Score of 11.3 and a Piotroski F-Score of 5.

Altman Z-Score	11.3
Piotroski F-Score	5